Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaflex plus Testosterone for Peyronie's Disease
NCT03815331Phase 4Completed
- Sponsor
- Men's Health Boston
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of testosterone undecanoate in Peyronie's disease, sponsored by Men's Health Boston. Started Jan 2019; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT03815331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03815331.